US Stock MarketDetailed Quotes

ESLA Estrella Immunopharma

Watchlist
  • 1.025
  • +0.010+0.99%
Trading May 20 14:18 ET
37.29MMarket Cap-2562P/E (TTM)

About Estrella Immunopharma Company

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies with the capacity to address treatment and safety challenges for patients with blood cancers and solid tumors. The company is headquartered in Emeryville, CA.

Company Profile

SymbolESLA
Company NameEstrella Immunopharma
Listing DateSep 14, 2021
CEODr. Cheng Liu, PhD
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5858 Horton Street,Suite 370
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-318-9098

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Cheng Liu, PhD
  • Chief Executive Officer, President and Director
  • --
  • Qian Yang
  • Chief Operating Officer
  • --
  • Jiandong Xu
  • Chief Financial Officer
  • --
  • Pei Xu
  • Independent Director
  • --
  • Janelle Wu
  • Independent Director
  • --
  • Fan Wu
  • Independent Director
  • --
  • Dr. Marsha Roberts
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg